口服抗凝药对急性A型主动脉夹层修复术后结局及假腔通畅性的影响
该研究回顾188例急性A型主动脉夹层修复术后患者,比较术后慢性口服抗凝(n=59)与单用抗血小板(n=129)的长期结局。中位随访8.4年,多因素校正后抗凝对长期生存(HR 0.85,95%CI 0.41-1.76,P=.66)和再干预风险(HR 0.55,95%CI 0.27-1.15,P=.11)无显著影响。抗凝组假腔部分血栓形成比例较低(8% vs 28%,P=.01),但假腔通畅不是晚期死亡或再手术的危险因素,抗凝可安全使用。
要点
- 慢性口服抗凝不显著影响修复术后长期生存和再干预风险。
- 抗凝组假腔部分血栓形成比例较低(8% vs 28%),但假腔通畅非不良结局危险因素。
- 修复术后患者可安全接受慢性抗凝治疗,无论其具体指征。
核心结论
- 慢性抗凝倾向于持续晚期假腔通畅,但假腔通畅不是晚期死亡或再手术的危险因素。
- 修复术后患者可安全接受慢性抗凝治疗,无论其具体指征。
研究设计与样本
- 回顾性比较研究,纳入188例急性A型主动脉夹层修复术后患者,中位年龄62岁,74%为男性。
- 抗凝组59例接受术后慢性口服抗凝,对照组129例仅接受抗血小板治疗。
主要发现
- 中位随访8.4年(2个月至30年),58例死亡,其中18例为主动脉相关原因,37例接受主动脉再干预。
- 多因素校正后,抗凝对长期生存无显著影响(HR 0.85,95%CI 0.41-1.76,P=.66),对再干预风险无显著影响(HR 0.55,95%CI 0.27-1.15,P=.11)。
- 127例术后CT分析显示,抗凝组假腔通畅53% vs 非抗凝组38%(P=.09),部分血栓形成8% vs 28%(P=.01),完全血栓形成39% vs 34%(P=.63)。
- 有对照CT的患者中,晚期主动脉相关死亡6例,抗凝组1例,非抗凝组5例。
- 抗凝组男性比例更高(88% vs 67%,P=.003),两组中位年龄相似(60岁 vs 64岁,P=.11)。
临床怎么用
- 急性A型主动脉夹层修复术后,因特定指征需要慢性抗凝的患者可安全使用口服抗凝药。
- 术后抗凝可能增加假腔持续通畅风险,但假腔通畅本身不增加晚期死亡或再手术风险。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to analyze the effects of chronic oral anticoagulation on long-term outcomes after repair of type A acute aortic dissection and its influence on false lumen fate. METHODS: We studied 188 patients (median age, 62 years; 74% were male) who underwent repair of type A aortic dissection; patients receiving postoperative chronic oral anticoagulation (n = 59) were compared with those receiving antiplatelet therapy alone (n = 129). RESULTS: Median age was similar: 60 years (18-79 years; OAC group) versus 64 years (22-86; no-OAC group) (P = .11); patients taking anticoagulants were more frequently male (88% vs 67%, P = .003). After a median follow-up of 8.4 years (2 months to 30 years), 58 patients died, 18 of aortic-related causes, and 37 patients underwent aortic reintervention. After multivariable adjustment, anticoagulation showed no significant effect on long-term survival (hazard ratio, 0.85; 95% confidence interval, 0.41-1.76; P = .66) or risk of reintervention (hazard ratio, 0.55; 95% confidence interval, 0.27-1.15; P = .11). Analysis of 127 postoperative computed tomography scans showed a patent false lumen in 53% of anticoagulated patients versus 38% of nonanticoagulated patients (P = .09): partially thrombosed in 8% versus 28% (P = .01) and thrombosed in 39% versus 34% (P = .63), respectively. In patients with a control computed tomography, there were 6 late aortic-related deaths, 1 among anticoagulated patients and 5 in those who were not. CONCLUSIONS: Chronic anticoagulation after repair of type A acute aortic dissection favors persistent late false lumen patency, which is not a risk factor for late mortality or reoperation. Chronic anticoagulation can be administered safely to patients with repaired type A acute aortic dissection regardless of its specific indication.
引用
- Vendramin I, Piani D, Lechiancole A, et al. Do oral anticoagulants impact outcomes and false lumen patency after repair of acute type A aortic dissection? J Thorac Cardiovasc Surg. 2021. PMID: 34583844. doi:10.1016/j.jtcvs.2021.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。